Delivery Order SPE2DE24D0013-SPE2D626F18TD
- Not listed
- On January 15, 2026, the Defense Logistics Agency Medical Supply Chain awarded a $20.4K delivery order (4570533435) to Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents. This firm fixed-price delivery order, with an ultimate completion date of January 23, 2026, represents a child contract under Cepheid's larger Indefinite Delivery Contract framework with the Department of Veterans Affairs. The award carries no set-aside designation,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,277.84 to Cepheid Inc. (Sunnyvale, CA) on January 14, 2026, with an ultimate completion date of January 22, 2026. This firm fixed-price delivery order, which carries no set-aside designation, is issued under a larger indefinite delivery contract vehicle and represents a child contract action. Cepheid, a leading manufacturer of molecular diagnostic systems and reagents, provides the GeneXpert diagnostic...
- On November 6, 2025, the Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,040.00 to Cepheid Inc. for molecular diagnostic supplies. This delivery order, identified as XPRS4PLEX-10, is structured as a firm fixed-price contract with an ultimate completion date of November 14, 2025, and carries no set-aside designation. The work will be performed at Cepheid's headquarters in Sunnyvale, California. This delivery order falls under a larger Indefinite Delivery...
- The Defense Logistics Agency Medical Supply Chain issued a delivery order valued at $4,320 to Cepheid Inc., a molecular diagnostic systems manufacturer headquartered in Sunnyvale, California, for delivery to the company's Sunnyvale facility. Awarded on January 9, 2026, with an ultimate completion date of January 16, 2026, this firm fixed-price delivery order carries no set-aside designation and represents a child contract under a larger indefinite delivery vehicle. Cepheid specializes in...
- Cepheid Inc., headquartered in Sunnyvale, California, received a delivery order valued at $1,500 awarded on January 20, 2026, by the Defense Logistics Agency Medical Supply Chain, with a completion deadline of January 27, 2026. This firm fixed-price delivery order, designated GXMRSA-NXG-10, carries no set-aside designation and represents a continuation of the contractor's extensive role as a federal supplier of molecular diagnostic solutions. The delivery order is issued under a larger...
- The Defense Logistics Agency Medical Supply Chain awarded a $2,392 firm fixed-price delivery order to Cepheid Inc. on November 24, 2025, with an ultimate completion date of December 2, 2025. This delivery order, designated XPRSTREPA-10, represents a small but targeted procurement under a larger indefinite delivery vehicle. Cepheid, headquartered in Sunnyvale, California, is a leading federal supplier of advanced molecular diagnostic systems and reagents, with particular expertise in the...
- On December 11, 2025, the Defense Logistics Agency Medical Supply Chain awarded a $27,200 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems. This delivery order, designated XPRS4PLEX-10, is scheduled for completion by December 18, 2025, and carries no set-aside designation. The award represents a single delivery order issued under Cepheid's existing Indefinite Delivery Contract vehicle with the Department of...
- The Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a delivery order valued at $4,791.90 to Cepheid Inc. on August 1, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order, identified as 4568960199 / GXCT/NG-10, carries no set-aside designation and will be performed in Sunnyvale, California. The award represents a discrete purchase of molecular diagnostic solutions from Cepheid, a leading manufacturer of advanced...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $2,040 firm fixed-price delivery order (4570533429) by the Defense Logistics Agency Medical Supply Chain on January 15, 2026. This delivery order, designated XPRS4PLEX-10, is expected to reach ultimate completion by January 23, 2026, and represents a child contract under a larger indefinite delivery vehicle. The award carries no set-aside designation and will be performed at Cepheid's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,040 on November 17, 2025, to Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems. This firm fixed-price delivery order, designated XPRS4PLEX-10 with completion slated for November 24, 2025, is issued under an existing Indefinite Delivery Contract framework. The award carries no set-aside designation, reflecting Cepheid's competitive positioning as an established...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F18TDDelivery Order
On January 21, 2026, the Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,720 to Cepheid Inc. for diagnostic supplies. This firm fixed-price delivery order, issued under the XPRS4PLEX-10 contract with an ultimate completion date of January 28, 2026, represents a child order under a larger Indefinite Delivery Vehicle. The award carries no set-aside designation and is being performed in Sunnyvale, California, where Cepheid is headquartered. The delivery order aligns with DLA's mission to provide medical logistics and supply chain support across the Department of Defense. Cepheid specializes in advanced molecular diagnostic systems and reagents for infectious disease detection, serving as a primary federal supplier of diagnostic solutions to multiple federal healthcare agencies including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and the U.S. Coast Guard. The company's GeneXpert diagnostic platform and associated testing capabilities support rapid molecular diagnostics for conditions including COVID-19, influenza, respiratory syncytial virus, and tuberculosis. This particular delivery order likely pertains to diagnostic reagents, test kits, or cartridges for the GeneXpert platform, consistent with Cepheid's extensive federal contracting history supplying similar solutions across the VA's Veterans Integrated Service Networks and other federal medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 1/20/26 |